Measles Cases in England Consistent With Waning of Vaccine Immunity
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- Measles cases in England are consistent with the waning of vaccine-induced immunity, according to a study published online Sept. 26 in The Lancet Public Health.
Alexis Robert, Ph.D., from the London School of Hygiene & Tropical Medicine, and colleagues examined whether measles dynamics observed in England between 2010 and 2019 were in line with waning of vaccine-induced immunity using a compartmental mathematical model stratified by age group, region, and vaccine status. The deterministic model was fitted under three scenarios: without waning of vaccine-induced immunity, with waning depending on time since vaccination, and with waning depending on time since vaccination starting in 2000.
The researchers found that the number of one-dose recipients among measles cases was overestimated in the scenario without waning, and the number of two-dose recipients was underestimated among cases older than 15 years (median, 75 cases in simulations without waning; 196 cases in simulations with waning; 188 cases in simulations when waning started in 2000; and 202 observed cases). The number of onward transmissions from vaccinated cases was 83 percent of transmissions from unvaccinated cases. There was a slow estimated waning rate (0.039 percent per year of age), but this was sufficient to increase the burden of measles.
"The waning of vaccine-induced immunity likely explains the observed dynamics and age distribution of vaccinated measles cases in England between 2010 and 2019," the authors write. "Many near-elimination countries have reported decreased vaccine coverage since 2020, leading to an increase in measles incidence in Europe in 2023."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Two Doses of Zoster Vaccine Reduce Risk for Herpes Zoster Ophthalmicus
TUESDAY, Aug. 19, 2025 -- Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute myocardial infarction, and...
Public Awareness Low About HPV, HPV Vaccination, HPV-Linked Cancer
THURSDAY, Aug. 14, 2025 -- Public awareness about human papillomavirus (HPV), HPV vaccination, and HPV-associated cancers is low, according to a research letter published online...
Many Not Up to Date With Vaccines Would Accept Shots During ED Visits
MONDAY, Aug. 11, 2025 -- Many individuals who are not up to date with recommended vaccinations would accept vaccines if offered during an emergency department visit, according to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.